COMP <GO>
IEX vs TMO // ENTERPRISE SCALE & MARKET CAP
IDEX Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: IEX 10
— TMO 4
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $233.84 (-2.29%) • MKT CAP: $17.58B
market-cap
$17.58B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IEX VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IEX | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.50% | 41.00% | +3.50 | IEX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.50% | 9.30% | +1.20 | IEX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.0x | 30.4x | -5.40 | IEX | /valuation <GO> |
| Free Cash Flow Yield | 3.51% | 2.40% | +1.11 | IEX | /fcf-yield <GO> |
| Operating Margin | 20.20% | 17.40% | +2.80 | IEX | /operating-margins <GO> |
| Net Profit Margin | 14.00% | 15.10% | -1.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 5.80% | 3.90% | +1.90 | IEX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.21% | 0.24% | +0.97 | IEX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.56 | 4.50 | +1.06 | IEX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.70% | -0.10 | IEX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.4 | 59.1 | -7.75 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.92 | 0.94 | -0.02 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.9x | 36.3x | -2.40 | IEX | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $17.58B | $262.22B | -$244.64B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IEX REV | TMO REV | IEX GROSS % | TMO GROSS % | IEX FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.46B | $44.56B | 44.5% | 44.0% | $616.8M | $6.29B |
| FY 2024 | $3.27B | $42.88B | 44.2% | 44.0% | $603.0M | $7.27B |
| FY 2023 | $3.27B | $42.86B | 44.0% | 44.0% | $569.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IEX // BETA 0.92
TMO // BETA 0.94